Back to Results

A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy

Study

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Barbara Davis Center
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Susan Boackle,  MD

Susan Boackle, MD

Study ID

Protocol Number: 20-0094

More information available at ClinicalTrials.gov: NCT04058028

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers